Clinical Trials

Study finds cannabis replacement therapy can be effective against addiction. Credit: 7raysmarketing from Pixabay. A new clinical trial led by the University of Sydney in Australia has shown that a cannabis-based medication called nabiximols could counter dependency on cannabis and minimise the rate of relapse in users. A publication by the university, in alliance with […]

Avicanna currently has the following clinical trials in progress or planned for the near future: CAIMED ( Centro de Atencion e Investigacion Medica CAIMED S.A.S.). Phase I studies are expected to commence in the second half of 2019 with CAIMED for certain cosmetic trials. University of West Indies. Avicanna is currently conducting a prevalence study […]

New countries in the expanded agreement include China, India, Indonesia, the Philippines, Thailand, Malaysia, Singapore and South Korea. Impression Healthcare (ASX: IHL) has extended the global coverage of its Fitguard by Gameday concussion monitoring system by extending its exclusive licensing agreement with Force Impact Technologies. The deal encompasses a great deal more territories with FiTGuard […]

Combining nabiximols — a cannabinoid agonist treatment — with psychosocial interventions may safely and effectively reduce cannabis dependence, according to a study published in JAMA Internal Medicine. “Cannabis dependence is associated with a range of cognitive, psychiatric and physical health problems and accounts for the second largest number of drug treatment episodes in Australia,” Nicholas […]

A paper about the University of Sydney and NSW Health clinical trial provides the first strong evidence that so-called cannabinoid agonist medication — which targets receptors in the brain — could reduce the rate of relapse. The paper published today in the American Medical Association’s JAMA Internal Medicine. Lead author Conjoint Professor Nick Lintzeris — […]

A study showed CBD might have antibiotic properties. The research was presented on June 23, 2019 at the annual meeting of the American Society for Microbiology.   Researchers found that CBD has a similar effect on bacteria to that of common antibiotics. It reportedly even worked against strains of staph and strep bacteria that have […]

AN Australian study has demonstrated that cannabis-based medication helps tackle dependency on cannabis. A paper about a University of Sydney and NSW Health clinical trial has provided the first strong evidence that so-called cannabinoid agonist medication – which targets receptors in the brain – can significantly reduce the rate of relapse. The paper was published […]

Study Examines Gadolinium Deposits in MS Patients’ Brains, But Still Can’t Determine Relationship with Disease Severity Here’s some new information about gadodiamide, a contrast dye that is injected during some MRIs. The study confirms that gadolinium, the substance on which gadodiamide is based, builds up in the brain, but the study doesn’t associate that buildup […]

The cannabidiol marketplace is likely to witness significant RD investment in the pharmaceutical industry as a broad-spectrum pharmaceutical therapeutics. Multiple scientific studies have shown promising results of cannabidiol for its potential in the treatment of a number of diseases. Following which the cannabidiol market is marked by a considerable cannabidiol therapeutics getting FDA approval or […]

The cannabidiol marketplace is likely to witness significant RD investment in the pharmaceutical industry as a broad-spectrum pharmaceutical therapeutics. Multiple scientific studies have shown promising results of cannabidiol for its potential in the treatment of a number of diseases. Following which the cannabidiol market is marked by a considerable cannabidiol therapeutics getting FDA approval or […]

Global Transdermal Gel Market is expected to rise at a stable CAGR of 12.31% in the forecast period of 2019-2026. Increasing health awareness among consumer is the major factor for the growth of this market. Key Market Competitors: Global Transdermal Gel Market Few of the major competitors currently working in the transdermal gel market are 3M, […]

Intec Pharma Ltd. (NASDAQ:NTEC) and Arena Pharmaceuticals Inc. (NASDAQ:ARNA) have been rivals in the Biotechnology for quite some time. Below is a review of each business including various aspects such as risk, institutional ownership, analyst recommendations, profitability, dividends, earnings and valuation. Valuation Earnings Table 1 demonstrates Intec Pharma Ltd. and Arena Pharmaceuticals Inc.’s gross revenue, […]